Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes.

Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes.

INTRODUCTION:Intensive treatment aimed at achieving optimal metabolic control to prevent the development of chronic diabetic complications is often associated with an increased rate of hypoglycemic events. Hypoglycemia is believed to be responsible for acute fatal and nonfatal cardiovascular events...

Full description

Bibliographic Details
Main Authors: Concetta Irace, Antonio Cutruzzolà, Delia Francesca Carbotti, Simona Mastroianni, Michela Cavallo, Agostino Gnasso
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0212871

Similar Items

Similar Items